Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-510
Closed -$26.3K 187
2023
Q4
$26.3K Sell
510
-2,187
-81% -$138K ﹤0.01% 88
2023
Q3
$180K Sell
2,697
-695
-20% -$51.6K 0.05% 29
2023
Q2
$232K Buy
3,392
+191
+6% +$11.1K 0.08% 44
2023
Q1
$185K Sell
3,201
-401
-11% -$25.3K 0.04% 92
2022
Q4
$128K Hold
3,602
0.01% 198
2022
Q3
$233K Hold
3,602
0.02% 245
2022
Q2
$500K Hold
3,602
0.04% 242
2022
Q1
$1.32M Hold
3,602
0.08% 272
2021
Q4
$1.09M Hold
3,602
0.07% 261
2021
Q3
$2.09M Hold
3,602
0.15% 181
2021
Q2
$3.74M Hold
3,602
0.18% 112
2021
Q1
$4.87M Hold
3,602
0.48% 75
2020
Q4
$4.37M Hold
3,602
0.85% 57
2020
Q3
$4.34M Hold
3,602
1.11% 30
2020
Q2
$3.78M Sell
3,602
-286
-7% -$317K 1.38% 14
2020
Q1
$5.17M Buy
+3,888
New +$6.78M 5.49% 6

Other funds holding PHGE

MMCAP International's PHGE Position: Q1 2024 in Review

MMCAP International sold out of BiomX (PHGE) in Q1 2024, closing a stake of 510 shares — an estimated $26.3K sold.

MMCAP International first reported a position in PHGE in Q1 2020 and held it in 16 quarters. The position peaked at $5.17M in Q1 2020. 9 funds tracked by Wall St. Rank hold PHGE as of Q1 2024.

  • MMCAP International reported no remaining BiomX position as of Q1 2024 after selling out during the quarter.
  • MMCAP International sold 510 BiomX shares in Q1 2024, an estimated $26.3K.
  • MMCAP International first reported a position in BiomX in Q1 2020 and held it in 16 quarters.
  • MMCAP International's BiomX position peaked at $5.17M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held BiomX as of Q1 2024.

Based on MMCAP International's 13F filing for Q1 2024, filed 9 May 2024.